Compile Data Set for Download or QSAR
maximum 50k data
Found 526 with Last Name = 'vasas' and Initial = 'a'
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249581(US9447038, 9)
Affinity DataIC50:  11nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM249581(US9447038, 9)
Affinity DataIC50:  11nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249658(US9447038, 86)
Affinity DataIC50:  12nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166453(US9073853, 12)
Affinity DataIC50:  13nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166453(US9073853, 12)
Affinity DataIC50:  13nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166545(US9073853, 104)
Affinity DataIC50:  15nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM249583(US9447038, 11)
Affinity DataIC50:  19nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166446(US9073853, 5)
Affinity DataIC50:  19nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249583(US9447038, 11)
Affinity DataIC50:  19nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166446(US9073853, 5)
Affinity DataIC50:  19nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166528(US9073853, 87)
Affinity DataIC50:  19nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 7(Homo sapiens (Human))
Les Laboratoires Servier

US Patent
LigandPNGBDBM507637(1-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-[[4-hydroxy...)
Affinity DataIC50:  19.6nMAssay Description:USP7 activity was measured using Rhodamine-110 c-terminal labelled Ubiquitin as a substrate (Viva Biosciences). Incubation with USP7 results in the r...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249763(US9447038, 191)
Affinity DataIC50:  20nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166447(US9073853, 6)
Affinity DataIC50:  20nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249609(US9447038, 37 | US9447038, 38)
Affinity DataIC50:  20nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249608(US9447038, 36)
Affinity DataIC50:  20nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM50200716(CHEMBL3916386)
Affinity DataIC50:  21nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166475(US9073853, 34)
Affinity DataIC50:  22nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166529(US9073853, 88)
Affinity DataIC50:  23nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM249577(US9447038, 5)
Affinity DataIC50:  23nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249577(US9447038, 5)
Affinity DataIC50:  23nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166529(US9073853, 88)
Affinity DataIC50:  23nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249615(US9447038, 43)
Affinity DataIC50:  23nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166451(US9073853, 10)
Affinity DataIC50:  24nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166455(US9073853, 14)
Affinity DataIC50:  25nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166466(US9073853, 25)
Affinity DataIC50:  25nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166455(US9073853, 14)
Affinity DataIC50:  25nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249647(US9447038, 75)
Affinity DataIC50:  25nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166589(US9073853, 148)
Affinity DataIC50:  26nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166589(US9073853, 148)
Affinity DataIC50:  26nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249720(US9447038, 148)
Affinity DataIC50:  28nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166477(US9073853, 36)
Affinity DataIC50:  28nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 7(Homo sapiens (Human))
Les Laboratoires Servier

US Patent
LigandPNGBDBM507626(3-[[4-hydroxy-1-[(3R,4R)-3-phenylpiperidine-4-carb...)
Affinity DataIC50:  28.7nMAssay Description:USP7 activity was measured using Rhodamine-110 c-terminal labelled Ubiquitin as a substrate (Viva Biosciences). Incubation with USP7 results in the r...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249696(US9447038, 124)
Affinity DataIC50:  30nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM249600(US9447038, 28)
Affinity DataIC50:  31nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249760(US9447038, 188)
Affinity DataIC50:  31nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249659(US9447038, 87)
Affinity DataIC50:  31nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249601(US9447038, 29)
Affinity DataIC50:  31nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 7(Homo sapiens (Human))
Les Laboratoires Servier

US Patent
LigandPNGBDBM507620(3-[[4-hydroxy-1-[(3R,4R)-3-phenylpiperidine-4-carb...)
Affinity DataIC50:  31.6nMAssay Description:USP7 activity was measured using Rhodamine-110 c-terminal labelled Ubiquitin as a substrate (Viva Biosciences). Incubation with USP7 results in the r...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM249596(US9447038, 24)
Affinity DataIC50:  32nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166450(US9073853, 9)
Affinity DataIC50:  32nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249596(US9447038, 24)
Affinity DataIC50:  32nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM249574(US9447038, 2)
Affinity DataIC50:  34nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249574(US9447038, 2)
Affinity DataIC50:  34nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C motif chemokine 10(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM249646(US9447038, 74)
Affinity DataIC50:  34nMT: 2°CAssay Description:The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166457(US9073853, 16)
Affinity DataIC50:  35nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166457(US9073853, 16)
Affinity DataIC50:  35nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM50200713(CHEMBL3915994)
Affinity DataIC50:  36nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166456(US9073853, 15)
Affinity DataIC50:  37nMAssay Description:Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 3(Homo sapiens (Human))
Sanofi

Curated by ChEMBL
LigandPNGBDBM166456(US9073853, 15)
Affinity DataIC50:  37nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 526 total ) | Next | Last >>
Jump to: